Twitter Feed
Have a look at this interesting article about "Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option"
▶️https://www.sciencedirect.com/science/article/pii/S0268960X2200042X
@GCC_Cortes @brummendorf @jvalentingg
#CML #TFR #TKI
Part one of the latest module of the iCMLf Knowledge Centre: ‘Management Practicalities’ is now available. The module features talks on topics about the practical management of #CML to help you in your clinical practice. Access the module here
Module 5: Management Practicalities - iCMLf Knowledge Centre
bit.ly
9 European Patient Umbrella Organizations form our Patient Cluster, Partners active in the different blood cancer areas to help us. Learn more: https://www.harmony-alliance.eu/patient-cluster
@AcuteLeuk
@CCIntOrg
@CLLAdvocates
@cmlnet
@knowyournodes
@mdsalliance
@myelomaEurope
@GMPNAN
@cci_europe
Great to work with these great colleagues on this review on management of CML. @brummendorf @CarloGambacorti @jvalentingg @GACancerCenter #jefflipton #mikedeininger https://www.sciencedirect.com/science/article/pii/S0268960X2200042X
Our Spanish member @Aelemic is excited to invite you to the VII National Congress for #CML Patients on 3-4 June, 2022.
More information, free registration and streaming:
#LMC #PatientAdvocacy #Members
@agalemo @asociacionalma @jvalentingg @GCC_Cortes
VII Congreso Nacional e Iberoamericano Pacientes Leucemia Mieloide Crónica. Aelemic 2022. - Aelemic
VII Congreso Nacional e Iberoamericano Pacientes de LMC. Aelemic Madrid 2022 AELEMIC te invita a asistir al VII Co...
aelemic.org